Skip to main content
. 2021 Apr 5;72(3):688–698. doi: 10.1007/s12020-021-02677-2

Table 1.

Baseline characteristics of male participants based on different metabolic obesity phenotypes

Overall (N = 6081) MHNO (N = 2001) MHO (N = 1989) MUNO (N = 551) MUO (N = 1540) p value
Age (years) 50.53 (14.11) 49.06 (15.15) 48.95 (12.42) 57.15 (15.25)ab 52.12 (13.50)abc <0.001
BMI (kg/m2) 25.69 (2.97) 22.87 (1.65) 27.31 (1.90)a 23.52 (1.17)ab 28.03 (2.29)abc <0.001
TC (mmol/L) 5.23 (0.93) 5.11 (0.90) 5.25 (0.88)a 5.25 (0.94)a 5.35 (1.00)ab <0.001
TG (mmol/L) 1.40 [0.99, 2.00] 1.07 [0.82, 1.41] 1.29 [1.00, 1.63]a 1.95 [1.39, 2.52]ab 2.09 [1.65, 2.80]abc <0.001
HDL-C (mmol/L) 1.26 (0.29) 1.38 (0.30) 1.27 (0.23)a 1.17 (0.31)ab 1.11 (0.25)abc <0.001
LDL-C (mmol/L) 3.03 (0.76) 2.93 (0.75) 3.13 (0.73)a 2.97 (0.77)b 3.05 (0.82)ab <0.001
SBP (mmHg) 127.57 (17.19) 119.96 (15.04) 124.78 (14.63)a 135.97 (17.15)ab 138.05 (16.45)abc <0.001
DBP (mmHg) 74.26 (11.26) 69.40 (9.81) 73.79 (10.20)a 76.16 (11.13)ab 80.49 (11.24)abc <0.001
FPG (mmol/L) 5.35 [4.98, 5.89] 5.16 [4.85, 5.52] 5.24 [4.93, 5.60]a 5.93 [5.30, 6.86]ab 5.96 [5.27, 6.90]ab <0.001
TSH (IU/mL) 1.76 [1.29, 2.37] 1.74 [1.27, 2.34] 1.79 [1.31, 2.37] 1.82 [1.27, 2.40] 1.75 [1.30, 2.41] 0.329
FT4 (pmol/L) 16.63 (1.97) 16.68 (1.96) 16.60 (2.00) 16.54 (1.91) 16.63 (1.96) 0.407
FT3 (pmol/L) 5.19 (0.52) 5.16 (0.51) 5.23 (0.51)a 5.11 (0.55)b 5.21 (0.52)ac <0.001
TPO-Ab positive (%) 480 (7.9) 147 (7.3) 163 (8.2) 48 (8.7) 122 (7.9) 0.664
ALT (IU/L) 23 [17, 31] 20 [15, 26] 24 [18, 32]a 22 [17, 28]ab 26 [19, 36]abc <0.001
AST (IU/L) 22 [19, 26] 21 [19, 25] 22 [19, 26]a 22 [19, 26]a 23 [19, 28]abc <0.001
Cr (μmol/L) 87.46 (13.10) 87.37 (13.03) 88.89 (12.62)a 85.00 (13.36)ab 86.60 (13.48)b <0.001
eGFR (mL/min/1.73m2) 87.80 [77.56, 102.47] 88.22 [78.38, 103.68] 86.57 [76.53, 99.51]a 89.59 [78.90, 103.75]b 88.54 [77.37, 103.34]b <0.001
Smoking (%) 2264 (37.2) 669 (33.4) 763 (38.4)a 208 (37.7) 624 (40.5)a <0.001

MHNO metabolically healthy nonobese, MHO metabolically healthy obese, MUNO metabolically unhealthy nonobese, MUO metabolically unhealthy obese, BMI body mass index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TSH thyroid-stimulating hormone, FT4 free thyroxine, FT3 free triiodothyronine, TPO-Ab thyroid peroxidase antibody, ALT alanine aminotransferase, AST aspartate aminotransferase, Cr creatinine, eGFR estimated glomerular filtration rate, SD standard deviation

Values with normal distribution are presented as mean (SD), and values without normal distribution are presented as median [25th percentile, 75th percentile]; categorical variables are presented as N (%). Statistically significant differences are shown with superscript letters: aSignificant difference compared with MHNO phenotype. bSignificant difference compared with MHO phenotype. cSignificant difference compared with MUNO phenotype